Affinage

SLC6A15

Sodium-dependent neutral amino acid transporter B(0)AT2 · UniProt Q9H2J7

Length
730 aa
Mass
81.8 kDa
Annotated
2026-04-28
24 papers in source corpus 12 papers cited in narrative 12 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

SLC6A15 (B0AT2) is a sodium-dependent neutral amino acid transporter expressed predominantly in neurons that supplies branched-chain amino acids, methionine, proline, and phenylalanine to the intracellular compartment, thereby coupling amino acid availability to glutamatergic neurotransmission, redox homeostasis, and stress-related behavior. Heterologous expression and knockout studies establish its preference for leucine, isoleucine, valine, and methionine (K0.5 80–160 µM), with transport that is temperature-sensitive, inhibited at acidic pH, and downregulated by PKC-mediated reduction of surface expression (PMID:16226721, PMID:17931606). In the hippocampus, SLC6A15 loss reduces tissue glutamate and glutamine yet raises extracellular glutamate, decreases glutamate release probability, alters GluR1 expression, and modulates anxiety- and depressive-like behaviors, while cell-type-specific manipulation in nucleus accumbens D2-medium spiny neurons bidirectionally controls stress susceptibility (PMID:26228428, PMID:26585320, PMID:28576941, PMID:33007132). Outside the brain, SLC6A15 transports phenylalanine into melanocytes to support melanin synthesis and is transcriptionally upregulated by UVB (PMID:41352278).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 2000 Low

    Establishing that SLC6A15 encodes a 12-transmembrane-domain SLC6-family protein that reaches the plasma membrane resolved its topology and set the stage for functional transport studies.

    Evidence Epitope-tagged expression with immunofluorescence in transfected cells

    PMID:11112352

    Open questions at the time
    • No transport activity measured; surface localization based on single tagged construct without endogenous validation
    • Glycosylation sites predicted but functional significance untested
  2. 2005 High

    Defining SLC6A15 as a Na+-coupled transporter selective for branched-chain amino acids and methionine, with PKC-regulated surface expression, established its substrate profile and a first regulatory mechanism.

    Evidence Radiolabeled uptake in Xenopus oocytes with kinetic, pH, temperature, and PKC analyses

    PMID:16226721

    Open questions at the time
    • Structural basis for substrate selectivity unknown
    • PKC-mediated internalization pathway not delineated
  3. 2007 High

    Demonstrating reduced synaptosomal proline and leucine uptake in Slc6a15-knockout mice proved that SLC6A15 contributes substantially to neutral amino acid transport at synapses in vivo.

    Evidence Slc6a15 KO mice with synaptosomal radiolabeled amino acid uptake

    PMID:17931606

    Open questions at the time
    • Residual uptake indicates redundant transporters not identified
    • Regional heterogeneity of contribution not mapped
  4. 2013 High

    Showing that SLC6A15 knockout attenuates leucine-induced anorexia and VMH neuronal activation, and that coding variants alter transport activity, connected SLC6A15 to nutrient sensing and demonstrated functional significance of human genetic variation.

    Evidence KO mice with ICV leucine injection, food intake, c-Fos IHC; cellular 3H-proline uptake with variant constructs

    PMID:23505546 PMID:23874702 PMID:24023709

    Open questions at the time
    • Downstream signaling from leucine sensing in VMH not characterized
    • Coding variants not tested in vivo
  5. 2015 High

    Bidirectional manipulation of hippocampal SLC6A15 revealed that it controls tissue glutamate/glutamine levels, extracellular glutamate tone, and GluR1 expression, linking its transport function to glutamatergic circuit modulation and anxiety/stress behavior.

    Evidence Slc6a15 KO and viral overexpression with HPLC, NMR, microdialysis, behavioral tests, and Western blot

    PMID:26228428 PMID:26585320

    Open questions at the time
    • Mechanism connecting neutral amino acid import to glutamate pool regulation not fully delineated
    • GluR1 regulation could be indirect
  6. 2017 High

    Cell-type-specific manipulation in NAc D2-medium spiny neurons demonstrated that SLC6A15 in this specific circuit node bidirectionally controls social stress susceptibility, placing the transporter in a defined neural circuit for stress resilience.

    Evidence Cre-inducible viral KD/OE in D2-Cre and A2A-Cre mice with social defeat paradigm

    PMID:28576941

    Open questions at the time
    • Amino acid changes in D2-MSNs upon manipulation not measured
    • Whether glutamatergic mechanism generalizes from hippocampus to NAc untested
  7. 2020 Medium

    In primary hippocampal neurons, SLC6A15 loss reduced glutamate release probability, enhanced mitochondrial function, shifted redox balance, and promoted neurite outgrowth, revealing pleiotropic neuronal consequences of altered amino acid import.

    Evidence KO hippocampal neurons with electrophysiology, Seahorse assay, glutathione quantification, and morphometry

    PMID:33007132

    Open questions at the time
    • Causal chain from amino acid depletion to mitochondrial and redox changes not resolved
    • In vivo relevance of neurite outgrowth phenotype unclear
  8. 2025 Medium

    Discovery that SLC6A15 transports phenylalanine into melanocytes to support melanogenesis expanded its physiological role beyond the CNS, showing it drives MITF/TYR/DCT expression and UVB-induced pigmentation.

    Evidence siRNA KD in MNT1 cells and primary melanocytes with melanin, phenylalanine, and gene expression assays

    PMID:41352278

    Open questions at the time
    • Whether phenylalanine effect is direct or via tyrosine conversion not distinguished
    • In vivo pigmentation phenotype in Slc6a15 KO mice not reported

Open questions

Synthesis pass · forward-looking unresolved questions
  • The structural basis for SLC6A15 substrate selectivity, the precise metabolic pathway linking neutral amino acid import to glutamate pool regulation, and the therapeutic potential of selective SLC6A15 inhibitors in stress-related disorders remain to be established.
  • No crystal or cryo-EM structure available
  • Metabolic flux from imported amino acids to glutamate/glutamine not traced
  • Selective inhibitors validated only in vitro and in primary neurons (preprint)

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0005215 transporter activity 4
Localization
GO:0005886 plasma membrane 2
Pathway
R-HSA-112316 Neuronal System 4 R-HSA-382551 Transport of small molecules 4
Partners

Evidence

Reading pass · 12 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2005 SLC6A15 (SBAT1) encodes a Na+-coupled transporter with strong preference for branched-chain amino acids (leucine, isoleucine, valine) and methionine (K0.5 80-160 µM), excluding aromatic or charged amino acids, β-amino acids, glycine, and GABA; transport is highly temperature-dependent (Q10=9) and inhibited at acidic pH; PKC activation reduces the plasma-membrane population of SBAT1 protein. Xenopus oocyte expression system with radiolabeled substrate uptake assays and PKC activation experiments Biochemical and biophysical research communications High 16226721
2007 Deletion of SLC6A15 (v7-3) in mice causes 15% and 40% reductions in sodium-dependent proline and leucine uptake into cortical synaptosomes, respectively, establishing SLC6A15 as a contributor to synaptosomal neutral amino acid transport in vivo. V7-3 knockout mice with synaptosomal amino acid uptake assays Brain research High 17931606
2013 SLC6A15 knockout mice show attenuated reduction of food intake and lower neuronal activation in the ventromedial hypothalamic nucleus (VMH) in response to intracerebroventricular leucine, demonstrating that SLC6A15 mediates leucine's anorexigenic effect in the brain. Slc6a15 KO mice with leucine injection, food intake measurement, and c-Fos immunohistochemistry in VMH PloS one High 23505546 24023709
2013 SLC6A15 protein (B0AT2) is localized predominantly to neurons (including GABAergic neurons and spinal cord motor neurons), with additional expression in astrocytes near ventricles and in choroid plexus epithelial cells (co-localizing with cytokeratin and diazepam binding inhibitor). Immunohistochemistry and in situ hybridization on mouse CNS tissue; co-localization with cell-type markers PloS one Medium 23505546
2015 Loss of SLC6A15 in mice reduces hippocampal tissue levels of proline and other neutral amino acids, decreases overall tissue glutamate and glutamine, yet increases basal extracellular glutamate tone; conversely, hippocampal SLC6A15 overexpression increases glutamate/glutamine tissue concentrations, linking SLC6A15 transport activity to glutamatergic neurochemistry. Slc6a15 KO mice and virus-mediated hippocampal overexpression with HPLC/NMR neurochemistry and in vivo microdialysis Journal of psychiatric research High 26228428
2015 SLC6A15 overexpression in the hippocampus increases anxiety-like behavior basally, while knockout reduces anxiety and depressive-like behavior after chronic social stress; GluR1 (AMPA receptor subunit) expression in the dentate gyrus is regulated by Slc6a15, suggesting glutamatergic modulation as a downstream mechanism. Slc6a15 KO mice and virus-mediated hippocampal overexpression with behavioral testing and Western blot for GluR1/GluR2/NR1 Stress (Amsterdam, Netherlands) Medium 26585320
2013 Two rare non-synonymous coding variants in SLC6A15 significantly increase maximal 3H-proline uptake compared to wild-type sequence, demonstrating that specific amino acid changes alter transporter activity. Cellular uptake assay with 3H-proline in cells expressing variant SLC6A15 constructs PloS one Medium 23874702
2017 Selective reduction of Slc6a15 in nucleus accumbens D2-medium spiny neurons (using Cre-inducible virus with D2-Cre or A2A-Cre mice) causes enhanced susceptibility to subthreshold social defeat stress, while restoration of Slc6a15 expression in D2-neurons prevents social avoidance after chronic social defeat stress, placing SLC6A15 in NAc D2-neurons as a regulator of stress susceptibility. Cre-inducible viral knockdown/overexpression in D2-Cre and A2A-Cre mice; social defeat stress paradigm with social interaction readout The Journal of neuroscience High 28576941
2020 Loss of SLC6A15 in primary hippocampal neurons reduces glutamate release probability at glutamatergic synapses, increases mitochondrial function, elevates GSH/GSSG redox ratio, and improves neurite outgrowth, demonstrating that SLC6A15 controls neutral amino acid concentrations that affect mitochondrial activity, synaptic function, and neuronal structure. Slc6a15-KO hippocampal neurons with proteomics, electrophysiology (release probability), Seahorse mitochondrial assay, glutathione assay, and neurite morphometry The European journal of neuroscience Medium 33007132
2025 SLC6A15 (B0AT2) transports phenylalanine into melanocytes, and its knockdown reduces intracellular phenylalanine levels, decreases melanin synthesis, downregulates MITF, TYR, and DCT expression, and abrogates UVB-induced pigmentation increase; UVB exposure transcriptionally upregulates SLC6A15. siRNA knockdown in MNT1 cells and primary melanocytes; Fontana-Masson staining; tyrosinase activity assay; intracellular phenylalanine measurement; RT-qPCR Journal of photochemistry and photobiology. B, Biology Medium 41352278
2025 First selective inhibitors of B0AT2/SLC6A15 were identified by HTS of 200,000 compounds using a 3H-proline uptake assay; a 1,5-benzodiazepine series inhibits SLC6A15 with IC50 ~250 nM in SLC6A15-overexpressing HEK293 cells and primary neurons, with no detectable inhibition of SERT, DAT, GAT1, or NTT4/SLC6A17; inhibitor treatment dose-dependently stimulates neurite outgrowth in primary neurons. High-throughput 3H-proline uptake assay; selectivity counter-screens vs. related SLC6 transporters; neurite outgrowth assay in primary hippocampal neurons bioRxivpreprint Medium bio_10.1101_2025.03.25.645215
2000 Human SLC6A15 (v7-3) encodes a protein with 12 predicted transmembrane domains, intracellular N- and C-terminal domains, large extracellular loops between TM3-4 and TM7-8, and N-linked glycosylation sites; when expressed with an epitope tag, v7-3 localizes to the cell surface, in contrast to the related NTT5 which is predominantly intracellular. Epitope-tagged transient transfection and subcellular localization by immunofluorescence Genomics Low 11112352

Source papers

Stage 0 corpus · 24 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2011 The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron 166 21521612
2005 Characterization of a branched-chain amino-acid transporter SBAT1 (SLC6A15) that is expressed in human brain. Biochemical and biophysical research communications 72 16226721
2017 Reduced Slc6a15 in Nucleus Accumbens D2-Neurons Underlies Stress Susceptibility. The Journal of neuroscience : the official journal of the Society for Neuroscience 39 28576941
2000 Cloning and characterization of human NTT5 and v7-3: two orphan transporters of the Na+/Cl- -dependent neurotransmitter transporter gene family. Genomics 39 11112352
2012 A variant of the neuronal amino acid transporter SLC6A15 is associated with ACTH and cortisol responses and cognitive performance in unipolar depression. The international journal of neuropsychopharmacology 32 22475622
2013 Involvement of the neutral amino acid transporter SLC6A15 and leucine in obesity-related phenotypes. PloS one 25 24023709
2015 The amino acid transporter SLC6A15 is a regulator of hippocampal neurochemistry and behavior. Journal of psychiatric research 22 26228428
2013 B(0)AT2 (SLC6A15) is localized to neurons and astrocytes, and is involved in mediating the effect of leucine in the brain. PloS one 22 23505546
2019 Edaravone presents antidepressant-like activity in corticosterone model of depression in mice with possible role of Fkbp5, Comt, Adora1 and Slc6a15 genes. Toxicology and applied pharmacology 21 31344373
2015 SLC6A15, a novel stress vulnerability candidate, modulates anxiety and depressive-like behavior: involvement of the glutamatergic system. Stress (Amsterdam, Netherlands) 21 26585320
2007 Deletion of v7-3 (SLC6A15) transporter allows assessment of its roles in synaptosomal proline uptake, leucine uptake and behaviors. Brain research 20 17931606
2023 The SLC6A15-SLC6A20 Neutral Amino Acid Transporter Subfamily: Functions, Diseases, and Their Therapeutic Relevance. Pharmacological reviews 19 37940347
1996 Widespread brain distribution of mRNA encoding the orphan neurotransmitter transporter v7-3. Brain research. Molecular brain research 19 8738154
2016 Effects of a Polymorphism of the Neuronal Amino Acid Transporter SLC6A15 Gene on Structural Integrity of White Matter Tracts in Major Depressive Disorder. PloS one 18 27723767
2019 Fine-scale haplotype mapping of MUT, AACS, SLC6A15 and PRKCA genes indicates association with insulin resistance of metabolic syndrome and relationship with branched chain amino acid metabolism or regulation. PloS one 15 30913280
2020 Loss of the psychiatric risk factor SLC6A15 is associated with increased metabolic functions in primary hippocampal neurons. The European journal of neuroscience 11 33007132
2013 Functional coding variants in SLC6A15, a possible risk gene for major depression. PloS one 11 23874702
2018 Withdrawal of caffeine after its chronic administration modifies the antidepressant-like activity of atypical antidepressants in mice. Changes in cortical expression of Comt, Slc6a15 and Adora1 genes. Psychopharmacology 8 29882086
2021 SLC6A15 acts as a tumor suppressor to inhibit migration and invasion in human papillary thyroid cancer. Journal of cellular biochemistry 7 33690923
2012 A conserved threonine in the S1-S2 loop of KV7.2 and K V7.3 channels regulates voltage-dependent activation. Pflugers Archiv : European journal of physiology 7 23271449
2017 A Combined Study of SLC6A15 Gene Polymorphism and the Resting-State Functional Magnetic Resonance Imaging in First-Episode Drug-Naive Major Depressive Disorder. Genetic testing and molecular biomarkers 3 28915082
2026 Phosphorylation-Dependent Regulation and Interactions of the Neutral Amino Acid Transporter SLC6A15: Implications for Major Depression and Neuropsychiatric Disorders. Omics : a journal of integrative biology 0 41649124
2025 UVB enhances SLC6A15-mediated phenylalanine transport to promote melanogenesis. Journal of photochemistry and photobiology. B, Biology 0 41352278
2024 LncRNA DGUOK-AS1 Promotes Cell Progression in Lung Squamous Cell Carcinoma by Regulation of miR-653-5p/SLC6A15 Axis. Molecular biotechnology 0 38407689